title: Aberrant membrane hormone receptors in incidentally discovered bilateral macronodular adrenal hyperplasia with subclinical Cushing's syndrome.
abstract: Cortisol secretion in adrenal Cushing's syndrome can be regulated by the aberrant adrenal expression of receptors for gastric inhibitory polypeptide, vasopressin, catecholamines, LH/human CG (LH/hCG), or serotonin. Four patients with incidentally discovered bilateral macronodular adrenal hyperplasia without clinical Cushing's syndrome were evaluated for the possible presence of aberrant adrenocortical hormone receptors. Urinary free cortisol levels were within normal limits, but plasma cortisol levels were slightly elevated at nighttime and suppressed incompletely after dexamethasone administration. Plasma ACTH was partially suppressed basally but increased after administration of ovine CRH. A 51-yr-old woman had ACTH-independent increases of plasma cortisol after 10 IU AVP im (292%), 100 microg GnRH iv (184%), or 10 mg cisapride orally (310%); cortisol also increased after administration of NaCl (3%), hCG, human LH, and metoclopramide. In a 61-yr-old man, cortisol was increased by AVP (349%), GnRH (155%), hCG (252%), and metoclopramide (191%). Another 53-yr-old male increased plasma cortisol after AVP (171%) and cisapride (142%). Cortisol secretion was also stimulated by vasopressin in a 54-yr-old female. This study demonstrates that subclinical secretion of cortisol can be regulated via the aberrant function of at least V1-vasopressin, LH/hCG, or 5-HT4 receptors in incidentally identified bilateral macronodular adrenal hyperplasia.
authors.affiliation: Division of Endocrinology, Department of Medicine, Research Center, Hôtel-Dieu and Hôpital Saint-Luc du Centre Hospitalier de l'Université de Montréal, Montréal, Canada H2W 1T8.
authors.forename: I
authors.initials: I
authors.lastname: Bourdeau
authors.forename: P
authors.initials: P
authors.lastname: D'Amour
authors.forename: P
authors.initials: P
authors.lastname: Hamet
authors.forename: J M
authors.initials: JM
authors.lastname: Boutin
authors.forename: A
authors.initials: A
authors.lastname: Lacroix
mesh_terms: D000312:Adrenal Hyperplasia, Congenital / Q000378:metabolism*; D020117:Cisapride; D003480:Cushing Syndrome / Q000378:metabolism*; D018492:Dopamine Antagonists / Q000494:pharmacology; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood; D007987:Gonadotropin-Releasing Hormone; D006728:Hormones / Q000378:metabolism*; D006801:Humans; D006854:Hydrocortisone / Q000097:blood / Q000652:urine; D008297:Male; D008566:Membranes / Q000378:metabolism; D008787:Metoclopramide / Q000494:pharmacology; D008875:Middle Aged; D011956:Receptors, Cell Surface / Q000378:metabolism*; D014667:Vasopressins
chemical_list: D018492:Dopamine Antagonists; D006728:Hormones; D011956:Receptors, Cell Surface; D014667:Vasopressins; D007987:Gonadotropin-Releasing Hormone; D005640:Follicle Stimulating Hormone; D008787:Metoclopramide; D020117:Cisapride; D006854:Hydrocortisone